Clinical Trials Logo
  1. Home
  2. Iron Deficiency Anemia
  3. NCT00198848
  4. Details
NCT00198848 Clinical Trial

Iron Supplementation Among Adolescent Girls in India

Iron Deficiency Anemia Clinical Trial

Official title:
Iron Supplementation Among Adolescent Girls in India

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00198848
Other study ID # H.32.04.11.22.A2
Secondary ID S3433-23/23 (ASP
Status Completed
Phase N/A
First received September 13, 2005
Last updated April 18, 2018
Start date September 2005
Est. completion date July 2007

Study information
Verified date January 2006
Source Johns Hopkins Bloomberg School of Public Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will implement and evaluate a community-based intervention to distribute and promote consumption of weekly iron-folic acid supplements and to provide nutrition education to reduce the prevalence of iron deficiency anemia among adolescent girls in West Bengal, India.

Recruitment information / eligibility
Status Completed
Enrollment 2800
Est. completion date July 2007
Est. primary completion date July 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 12 Years to 19 Years
Eligibility Inclusion Criteria:

- Girl 12-19 years of age

- Resides in study area

Exclusion Criteria:

- Does not reside in study area

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Iron-folic acid supplement

Locations
Country Name City State
India Child In Need Institute Kolkata West Bengal

Sponsors (2)
Lead Sponsor Collaborator
Johns Hopkins Bloomberg School of Public Health Centers for Disease Control and Prevention

Country where clinical trial is conducted

India, 

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of anemia after 1 year of intervention
Secondary Knowledge of anemia
Secondary Practices regarding treatment and prevention of anemia
Secondary Knowledge of iron supplements
Secondary Practices regarding iron supplements
Secondary Dietary iron intake
See also
  Status Clinical Trial Phase
Recruiting NCT06027801 - Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity N/A
Completed NCT02282553 - Gastric Capsule Examination for Iron Deficiency Anaemia N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT04913649 - Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients Phase 4
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01307007 - Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Phase 2
Completed NCT00982007 - Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Phase 3
Completed NCT01166451 - The Anemia Control Program: High or Low Iron Supplementation N/A
Recruiting NCT03893045 - A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects Phase 3
Recruiting NCT03817957 - Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency Phase 3
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Completed NCT03618914 - Anemia and Inflammation
Completed NCT03940430 - Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students Phase 2/Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Completed NCT03237065 - Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Phase 3
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
Completed NCT03238911 - Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Phase 3